- Home
- AGMH vs SCNI Comparison
AGMH vs SCNI Comparison
Compare AGMH & SCNI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AGMH | SCNI |
|---|---|---|
| Founded | 2015 | 2003 |
| Country | Hong Kong | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1M | 2.2M |
| IPO Year | 2017 | 2014 |
Fundamental Metrics
Financial Performance| Metric | AGMH | SCNI |
|---|---|---|
| Price | $0.89 | $0.57 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 60.1K | ★ 7.3M |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 50.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $0.07 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.06 | $0.45 |
| 52 Week High | $18.10 | $6.18 |
Technical Indicators
Market Signals| Indicator | AGMH | SCNI |
|---|---|---|
| Relative Strength Index (RSI) | 42.48 | 44.38 |
| Support Level | $0.81 | $0.54 |
| Resistance Level | $0.94 | $1.02 |
| Average True Range (ATR) | 0.06 | 0.11 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 46.47 | 16.92 |
Price Performance
Historical ComparisonAbout AGMH AGM Group Holdings Inc.
AGM Group Holdings Inc is an integrated technology company. The company focuses on blockchain-oriented ASIC chip design, high-end crypto miner production, and fintech technology software services. The company generates maximum revenue from the sale of cryptocurrency mining machines and standardized computing equipment.
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units: (i) Scinai R&D, focused on the development of therapeutics in inflammation and immunology, and (ii) the contract development and manufacturing organization (CDMO) business. The CDMO business provides integrated development and manufacturing services to small and emerging biotech companies, supporting clients from early-stage development through clinical-stage production.